线粒体移植改善小鼠心脏骤停复苏后的结局
该研究在成年C57BL/6小鼠和Sprague-Dawley大鼠心脏骤停复苏模型中,静脉输注物种匹配的供体线粒体,评估72小时生存与神经功能。结果显示线粒体移植组72小时生存率为33.3%,对照组为0%(P=0.006),神经功能评分改善,脑水肿减轻。移植线粒体在心脏骤停后脑和脾中摄取显著增强,循环髓系细胞快速内化功能性线粒体(摄取率53.9% vs 10.6%,P<0.001)。线粒体移植下调Fission 1、保留Mitofusin 2,上调Hmox1、Sirt1、Entpd1等保护基因,并减少促炎巨噬细胞、增加细胞毒性T细胞。
要点
- 小鼠心脏骤停复苏后静脉线粒体移植,72小时生存率33.3% vs 对照0%(P=0.006)。
- 线粒体移植改善神经功能评分并减轻脑水肿。
- 心脏骤停后脑和脾对移植线粒体摄取增强,循环髓系细胞摄取率53.9% vs 对照10.6%(P<0.001)。
- 线粒体移植减少促炎巨噬细胞、增加细胞毒性T细胞,下调Fission 1、保留Mitofusin 2,上调Hmox1、Sirt1、Entpd1。
适用人群与场景
- 成年C57BL/6小鼠和Sprague-Dawley大鼠心脏骤停复苏模型。
处置流程与药物剂量
- 心脏骤停复苏后静脉输注物种匹配的供体线粒体(MTx)。
研究设计与关键结果
- 研究类型:动物实验(小鼠和大鼠心脏骤停复苏模型)。
- 干预与对照:静脉线粒体移植 vs 载体治疗。
- 主要终点:72小时生存率33.3% vs 0%(P=0.006),神经功能评分改善。
- 次要终点:脑水肿减轻;脑和脾对移植线粒体摄取增强;循环髓系细胞摄取率53.9% vs 10.6%(P<0.001)。
- 免疫与基因表达:促炎巨噬细胞减少、细胞毒性T细胞增加;Fission 1下调、Mitofusin 2保留、Hmox1、Sirt1、Entpd1上调。
证据类型、等级与局限
- 证据类型:动物实验(小鼠和大鼠)。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Mitochondrial transplantation (MTx) is an emerging strategy for restoring cellular bioenergetics and mitigating ischemia-reperfusion (IR) injury. We previously demonstrated that MTx improved neurological outcomes and survival in a rat model of cardiac arrest (CA). However, the mechanisms underlying these benefits, particularly regarding immune modulation and transcriptional regulation, remain unclear.
METHODS: Adult C57BL/6 mice and Sprague-Dawley rats underwent CA and resuscitation protocols, followed by intravenous MTx with species-matched donor mitochondria. Survival and neurological outcomes were assessed up to 72 h. Biodistribution and cellular uptake of fluorescent dye-labeled mitochondria were analyzed via in vivo imaging and flow cytometry. Gene expression related to mitochondrial dynamics, inflammation, and immune regulation was evaluated using qPCR.
RESULTS: MTx improved 72-hour survival (33.3% vs. 0%, P = 0.006) and neurological scores compared to vehicle treatment. Reduced brain edema was observed in MTx-treated animals. Mitochondrial uptake was significantly enhanced in the brain and spleen post-CA, with key infiltrating and resident immune cell populations-including monocytes, macrophages, microglia, astrocytes, and endothelial cells-preferentially internalizing transplanted mitochondria. Circulating myeloid cells rapidly internalized functional mitochondria, with 53.9% uptake in MTx-treated CA animals versus 10.6% in controls (P < 0.001). MTx also modulated immune profiles, reducing pro-inflammatory macrophages and enhancing cytotoxic T cell numbers. Gene expression analysis showed that MTx downregulated Fission 1, preserved Mitofusin 2, and upregulated protective genes, including Hmox1, Sirt1, and Entpd1.
CONCLUSIONS: MTx improves outcomes after CA, accompanied by mitochondrial uptake by immune cells and redistribution to injured tissues. This process likely modulates immune responses, enhances mitochondrial fusion, and activates cytoprotective gene expression.
参考来源
- Aoki T, Endo Y, Yin T, et al. Mitochondrial transplantation improves outcomes after cardiac arrest and resuscitation in mice. Resuscitation. 2025. PMID: 39947277. doi:10.1016/j.resuscitation.2025.110535
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。